Volume 25, Number 4—April 2019
Dispatch
Aerosol Transmission of Aspergillus fumigatus in Cystic Fibrosis Patients in the Netherlands
Tobias G.P. Engel
, Ellen Erren, Koen S.J. Vanden Driessche, Willem J.G. Melchers, Monique H. Reijers, Peter Merkus, and Paul E. Verweij
, Ellen Erren, Koen S.J. Vanden Driessche, Willem J.G. Melchers, Monique H. Reijers, Peter Merkus, and Paul E. Verweij
Table
Characteristics of and growth of Aspergillus fumigatus, Pseudomonas aeruginosa, Staphylococcus aureus, and Stenotrophomonas maltophilia in sputum samples and on cough plates from 15 cystic fibrosis patients, the Netherlands, 2017–2018*
| Pt. no. |
Age, y/sex |
FEV1, L (% predicted) |
Peak flow,
L/s |
AB/AF use |
Growth on first/second cough plates | Cultured from first/second sputum sample | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A. fumigatus |
P. aeruginosa |
S. aureus |
S. maltophilia |
A. fumigatus |
P. aeruginosa |
S. aureus |
S. maltophilia |
||||||
| 1 | 23/F | 2.7 (85) | 7.9 | Yes/no | –/– | +/– | –/– | –/– | –/– | +/+ | +/+ | +/– | |
| 2 | 20/F | 4.0 (101) | 8.6 | Yes/no | –/– | –/– | –/– | –/+ | –/ND | –/ND | +/ND | +/ND | |
| 3 | 22/F | 2.3 (74) | 7.9 | Yes/no | –/– | –/– | –/+ | –/– | +/+ | –/– | +/+ | –/– | |
| 4 | 20/M | 3.2 (61) | 7.4 | Yes/no | +/– | –/– | –/– | –/– | +/+ | –/– | +/+ | –/– | |
| 5 | 49/F | 2.3 (74) | 7.7 | No/no | –/– | –/– | –/– | –/– | +/– | –/– | +/+ | –/– | |
| 6 | 43/F | 2.7 (82) | 7.2 | Yes/no | –/– | –/– | –/– | –/– | +/+ | +/+ | –/– | –/– | |
| 7 | 26/M | 4.6 (106) | 10.9 | Yes/no | –/– | –/– | +/+ | –/– | +/ND | –/ND | +/ND | –/ND | |
| 8 | 39/F | 1.0 (33) | 5.7 | Yes/no | –/– | –/– | –/+ | –/– | +/+ | –/– | –/– | +/+ | |
| 9 | 49/M | 1.2 (31) | 3.4 | Yes/no | –/– | +/+ | –/– | –/– | +/+ | +/+ | –/– | –/– | |
| 10 | 22/M | 2.0 (41) | 7.8 | Yes/no | –/– | +/+ | –/– | –/– | +/– | +/+ | +/+ | –/– | |
| 11 | 58/F | 2.2 (79) | 5.1 | Yes/no | –/– | –/– | –/– | –/– | –/– | +/+ | +/– | –/– | |
| 12 | 31/M | 2.0 (41) | 5.3 | Yes/no | –/– | +/+ | +/+ | –/– | –/+ | –/+ | –/+ | –/– | |
| 13 | 51/F | 0.7 (26) | 3.5 | Yes/no | –/– | +/+ | –/– | –/– | –/– | +/+ | +/+ | –/– | |
| 14 | 30/M | 2.5 (50) | 8.7 | Yes/no | –/– | +/+ | –/– | –/– | +/+ | +/+ | –/– | –/+ | |
| 15 | 27/F | 3.8 (102) | 8.4 | Yes/no | +/+ | –/– | –/– | –/– | +/+ | –/– | –/– | –/– | |
*AB, antibiotic; AF, antifungal; FEV1, forced expiratory volume in 1 second; ND, not done; Pt, patient; +, positive; –, negative.
Page created: March 18, 2019
Page updated: March 18, 2019
Page reviewed: March 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.